<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="437">
  <stage>Registered</stage>
  <submitdate>7/09/2005</submitdate>
  <approvaldate>8/09/2005</approvaldate>
  <actrnumber>ACTRN12605000336684</actrnumber>
  <trial_identification>
    <studytitle>Stay Active, Strong and Healthy study (SASH)</studytitle>
    <scientifictitle>Evaluation of a community-based strength training model on HbA1c in people with Type 2 diabetes</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Type 2 diabetes</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>progressive resistance training for the duration of 12 months</interventions>
    <comparator>home based resistance training for the duration of 12 months</comparator>
    <control>Dose comparison</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in HbA1c between 0, 2, and 14 months</outcome>
      <timepoint>At 0, 2 and 14 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Exercise adherence</outcome>
      <timepoint>Changes between 0, 2, and 14 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Insulin and insulin sensitivity</outcome>
      <timepoint>Changes between 0, 2, and 14 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Self-monitored glucose</outcome>
      <timepoint>Changes between 0, 2, and 14 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Muscle strength</outcome>
      <timepoint>Changes between 0, 2, and 14 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Body composition</outcome>
      <timepoint>Changes between 0, 2, and 14 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Blood pressure</outcome>
      <timepoint>Changes between 0, 2, and 14 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Self-efficacy</outcome>
      <timepoint>Changes between 0, 2, and 14 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Quality of life</outcome>
      <timepoint>Changes between 0, 2, and 14 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Emotional well being</outcome>
      <timepoint>Changes between 0, 2, and 14 months.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>overweight (BMI &gt; 27 &lt; 40kg/m2) males and females, established (&gt;6 months) Type 2 diabetes, not on insulin therapy, HbA1c 7.0 - 10.0%, lifestyle - sedentary and non- smokers.Criteria developed by the American College of Sports Medicine for absolute contraindications to exercise participation were used to assess eligibility for participation. </inclusivecriteria>
    <inclusiveminage>40</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Poorly treated hypertensives (anti-hypertensive medication and BP &gt; 180/95 on at least 2 occasions or untreated hypertensives (BP &gt; 180/95 on at least 2 occasions) were excluded</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed envelopes were held by an independent person, and opened by the independent person to assign the intervention group.</concealment>
    <sequence>Computer-generated random numbers (Excel), in blocks.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/03/2002</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Charities/Societies/Foundations</primarysponsortype>
    <primarysponsorname>VicHealth</primarysponsorname>
    <primarysponsoraddress>melbourne, VIC</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>VicHealth</fundingname>
      <fundingaddress>melbourne, VIC</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Other</sponsortype>
      <sponsorname>International Diabetes Institute</sponsorname>
      <sponsoraddress>250 Kooyong Rd, Caulfield, VIC</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>International Diabetes Institute Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>A/Professor Jonathan Shaw</name>
      <address>International Diabetes Institute
250 Kooyong Rd
Caulfield Melbourne VIC 3162</address>
      <phone>+61 3 92585000</phone>
      <fax>+61 3 92585902</fax>
      <email>jshaw@idi.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Mrs Elena Vulikh</name>
      <address>International Diabetes Institute
250 Kooyong Rd
Caulfield Melbourne VIC 3162</address>
      <phone>+61 3 92585000</phone>
      <fax>+61 3 92585902</fax>
      <email>evulikh@idi.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>